Additionally, case reports and prospective cohort studies of patients treated with GLP-1 RAs have demonstrated reductions in the Psoriasis Area and Severity Index (PASI) score, Physicians Global Assessment (PGA), and Dermatology Life Quality Index (DLQI) after 212 months of treatment [11,12,13,14,15,16]
Further, new strategies targeting non-coding RNAs, and epigenetic regulators emphasize ferroptosis as a viable therapeutic target
Annals Clin Biochemistry: Int J Lab Med
But here's what most providers won't tell you: sourcing matters enormouslyand the difference between pharmaceutical-grade peptides from a licensed Florida 503A compounding pharmacy and grey-market peptides sold online could be the difference between safe, effective treatment and genuine risk